Due to some rare but serious side effects, the FDA is ordering new warnings for the labels of prescription sleep aids. The makers of all sedative-hypnotic drugs have been ordered to strengthen their warning labels regarding the risk of “complex sleep-related behaviors” and severe allergic reactions. Some of the potential adverse effects include driving and eating while asleep, with no memory of the event. The FDA decided that additional warnings were necessary after reviewing post-marketing data. The following 13 drugs are affected by this FDA action: Ambien, Butisol Sodium, Carbrital, Darmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem, Seconal and Sonata.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.